argus

Supriya Lifescience Limited

NSE: SUPRIYAINE07RO010276,464 Cr

Timeline

Time (IST)TypeMEventSrc
01 Sept, 07:49 pmprocedural0Filing of the Reg. 34(1) Annual Report, a routine statutory disclosure with no standalone investor information.bse
26 Aug, 05:29 pmSupriya Lifescience Limited has informed the Exchange that Record date for the purpose of Dividend is 04-Sep-2026.nse
26 Aug, 05:29 pmSupriya Lifescience Ltd - 543434 - Record Date For Determining Members Eligible To Receive Dividend For The Financial Year 2025-26.bse
18 Aug, 04:37 pmSupriya Lifescience Limited has informed the Exchange about Transcriptnse
18 Aug, 04:37 pmSupriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
14 Aug, 05:21 pmSupriya Lifescience Limited has informed the Exchange about Link of Recordingnse
14 Aug, 05:20 pmSupriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
13 Aug, 11:27 pmSupriya Lifescience Limited has informed the Exchange regarding a press release dated August 13, 2026, titled "Press Release for Unaudited Financial Results for quarter ended June 30, 2026".nse
13 Aug, 11:26 pmSupriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
13 Aug, 07:38 pmSupriya Lifescience Limited has informed the Exchange regarding 'Unaudited Financial Results for Quarter ended June 30, 2026'.nse
13 Aug, 07:28 pmSupriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
13 Aug, 07:27 pmSupriya Lifescience Limited has informed the Exchange about Investor Presentationnse
13 Aug, 06:48 pmSupriya Lifescience Ltd - 543434 - Unaudited Financial Results For The Quarter Ended June 30, 2026.bse
13 Aug, 06:40 pmPursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its Meeting held on Thursday, August 13, 2026, inter-alia considered and approved Unaudited Financial Results for the Quarter ended June 30, 2026. A copy of the same is enclosed along with the Limited Review Report of the Statutory Auditors thereon in terms of SEBI (LODR) Regulations, 2015. The Meeting of the Board of Directorsnse
06 Aug, 06:23 pmSupriya Lifescience Ltd - 543434 - Board Meeting Intimation for Unaudited Financial Results For Quarter Ended June 2026bse
04 Jul, 10:34 amSupriya Lifescience Limited has informed the Exchange about General Updatesnse
04 Jul, 05:20 amSupriya Lifescience Ltd - 543434 - Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015.bse
29 Jun, 04:17 pmSatish Waman Wagh has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
23 Jun, 05:25 pmSupriya Lifescience Limited has informed the Exchange about General Updatesnse
23 Jun, 05:25 pmSupriya Lifescience Ltd - 543434 - Email Communication To Shareholders Regarding Dividend Taxation Provisions.bse
02 Jun, 04:12 pmSupriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
02 Jun, 04:10 pmSupriya Lifescience Limited has informed the Exchange about Transcriptnse
30 May, 02:39 pmSupriya Lifescience Ltd - 543434 - Compliances-Reg.24(A)-Annual Secretarial Compliancebse
28 May, 04:05 pmSupriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
28 May, 04:01 pmSupriya Lifescience Limited has informed the Exchange about Link of Recordingnse
28 May, 09:14 amSupriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
28 May, 09:13 amSupriya Lifescience Limited has informed the Exchange regarding a press release dated May 28, 2026, titled "Press Release - Audited Financial Results for quarter and year ended March 31, 2026".nse
27 May, 07:09 pmSupriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
27 May, 07:09 pmSupriya Lifescience Limited has informed the Exchange about Investor Presentationnse
27 May, 06:56 pmSupriya Lifescience Ltd - 543434 - Corporate Action-Board to consider Dividendbse
27 May, 06:41 pmSupriya Lifescience Ltd - 543434 - Audited Financial Results For Quarter And Year Ended March 31, 2026bse
27 May, 06:40 pmSupriya Lifescience Limited has informed the Exchange that Board of Directors at its meeting held on May 27, 2026, recommended Final Dividend of Re. 1 per equity share.nse
27 May, 06:33 pmSupriya Lifescience Ltd - 543434 - Board Meeting Outcome for Outcome Of Board Meetingbse
27 May, 06:32 pmSupriya Lifescience Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.nse
20 May, 04:59 pmSupriya Lifescience Ltd - 543434 - Board Meeting Intimation for Audited Financial Results Of The Company For The Quarter And Year Ended March 31, 2026 And Recommend Dividend, If Any, On The Equity Shares Of The Company For The Financial Year Ended March 31, 2026.bse
30 Apr, 03:05 pmSupriya Lifescience Ltd - 543434 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure Abse
22 Apr, 11:48 amDisclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Update on inspection by United States Food & Drug Administration (USFDA)nse
24 Mar, 05:41 pmSupriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Change in Directoratebse
24 Mar, 05:40 pmSupriya Lifescience Limited has informed the Exchange regarding Change in Director(s) of the company.nse
13 Mar, 03:41 pmThe Exchange had sought clarification from Supriya Lifescience Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Segment details not submitted. The response of the Company is enclosed.nse
10 Mar, 02:44 pmThe Exchange has sought clarification from Supriya Lifescience Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted. The response of the Company is awaited.nse
17 Feb, 10:51 amSupriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
17 Feb, 10:47 amSupriya Lifescience Limited has informed the Exchange about Transcriptnse
10 Feb, 04:25 pmSupriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
10 Feb, 04:23 pmSupriya Lifescience Limited has informed the Exchange about Link of Recordingnse
10 Feb, 01:10 pmSupriya Lifescience Limited has informed the Exchange about Copy of Newspaper Publication of Unaudited Financial Results of the Company for quarter and nine months ended December 31, 2025 is enclosed.nse
10 Feb, 01:06 pmSupriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
10 Feb, 01:05 pmSupriya Lifescience Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Press Release- Unaudited Financial Results for the Quarter and Nine Months ended December 31, 2025.".nse
09 Feb, 07:58 pmSupriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
09 Feb, 07:58 pmSupriya Lifescience Limited has informed the Exchange about Investor Presentationnse